Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy ADMA Biologics (ADMA) shares

Learn how to easily invest in ADMA Biologics shares.

ADMA Biologics is a biotechnology business based in the US. ADMA Biologics stocks (ADMA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.43 – an increase of 15.91% over the previous week. ADMA Biologics employs 527 staff and has a trailing 12-month revenue of around $80.9 million.

How to buy stocks in ADMA Biologics

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADMA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

ADMA Biologics stock price (NASDAQ:ADMA)

Use our graph to track the performance of ADMA stocks over time.

ADMA Biologics shares at a glance

Information last updated 2022-05-19.
Latest market close$2.04
52-week range$1.01 - $2.16
50-day moving average $1.83
200-day moving average $1.49
Wall St. target price$5.13
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.51

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get $500 in commission free trades when you fund your account with a minimum of $10,000. Conditions apply. Ends August 31st, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy ADMA Biologics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

ADMA Biologics price performance over time

Historical closes compared with the close of $2.04 from 2022-05-20

1 week (2022-05-11) N/A
1 month (2022-04-22) 2.51%
3 months (2022-02-18) N/A
6 months (2021-11-22) 40.69%
1 year (2021-05-21) 15.91%
2 years (2020-05-21) -29.90%
3 years (2019-05-21) 4.34
5 years (2017-05-19) 3.74

ADMA Biologics financials

Revenue TTM $80.9 million
Gross profit TTM $1.2 million
Return on assets TTM -14.87%
Return on equity TTM -62.46%
Profit margin -88.52%
Book value $0.72
Market capitalisation $394.7 million

TTM: trailing 12 months

ADMA Biologics share dividends

We're not expecting ADMA Biologics to pay a dividend over the next 12 months.

ADMA Biologics share price volatility

Over the last 12 months, ADMA Biologics's shares have ranged in value from as little as $1.01 up to $2.155. A popular way to gauge a stock's volatility is its "beta".

ADMA.US volatility(beta: 1.16)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ADMA Biologics's is 1.1632. This would suggest that ADMA Biologics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

ADMA Biologics overview

ADMA Biologics, Inc. , a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site